- Report
- July 2025
- 383 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 898 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 363 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- May 2025
- 150 Pages
Global
From €2635EUR$2,999USD£2,273GBP
- Report
- August 2024
- 135 Pages
Global
From €2635EUR$2,999USD£2,273GBP
- Report
- June 2025
- 400 Pages
Global
From €4349EUR$4,949USD£3,751GBP
- Report
- June 2025
- 400 Pages
Global
From €4349EUR$4,949USD£3,751GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1757EUR$2,000USD£1,516GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1757EUR$2,000USD£1,516GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1757EUR$2,000USD£1,516GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1318EUR$1,500USD£1,137GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1318EUR$1,500USD£1,137GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1098EUR$1,250USD£947GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Report
- September 2024
- 132 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- August 2024
- 233 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- January 2025
- 180 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1757EUR$2,000USD£1,516GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more